Physician profile
Danielle Fong
NPI 1053075614
$1,146.69
in general payments reported to CMS, 2019-2025
16 companies · $311 in 2025
The $311 reported for 2025 was more than what 90% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.91 · 2022: $199 · 2023: $170 · 2024: $447 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $462.30 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $90.55 | 2022-2025 | Novasure, Aptima, Myosure Tissue Removal Device |
| Abbvie INC. | $81.34 | 2022-2023 | |
| Coopersurgical, INC. | $76.33 | 2021-2025 | Paragard T 380a |
| Myriad Women'S Health, INC. | $72.98 | 2023 | Myrisk |
| Baxter Healthcare | $60.99 | 2022-2025 | Perclot |
| Shield Therapeutics INC | $53.65 | 2024 | |
| Exeltis, USA INC. | $52.60 | 2024-2025 | Slynd |
| Daiichi Sankyo INC. | $42.02 | 2022 | |
| Mayne Pharma Commercial LLC | $36.82 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $24.90 | 2022 | |
| Organon LLC | $24.14 | 2024 | |
| Becton, Dickinson and Company | $21.48 | 2025 | Bd Onclarity |
| Millicent US INC | $18.22 | 2024 | Intrarosa, Femring |
| Electromed, INC. | $14.90 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Fong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.